Clinical Trial Update: A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

Phase I clinical trial update for HLX37 evaluating safety, tolerability, and pharmacokinetics in advanced/metastatic solid tumors. The study includes non-small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• HLX37

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Advanced/Metastatic Solid Tumors, NSCLC | EARLY_Phase 1 | Status: RECRUITING